TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy

Montefiore Medical Center, The Bronx

Taipei Veterans General Hospital, Taipei

Roswell Park Cancer Institute, Buffalo

Thomas Jefferson University Hospital, Philadelphia

Georgetown University Medical Center, Washington D.C.

Walter Reed Army Institute of Research, Bethesda

Harry and Jeanette Weinberg Cancer Institute at Franklin Square, Baltimore

Virginia Cancer Specialists, PC, Fairfax

Pius Hospital Oldenburg, Oldenburg

Duke University Medical Center, Durham

Hospital Universitario Ramón y Cajal, Madrid

Hollings Cancer Center, Charleston

Cancer Specialists of North Florida, Fleming Island

Florida Hospital Cancer Institute, Orlando

Advanced Medical Specialties, Miami

Chang Gung Memorial Hospital Linkou, Taoyuan District

Cleveland Clinic Florida, Weston

Florida Cancer Specialists, St. Petersburg

Florida Cancer Specialists and Research Institute, Fort Myers

University of Alabama at Birmingham, Birmingham

Tennessee Oncology, PLLC, Nashville

Tennessee Oncology, PLLC, Chattanooga

Taichung Veterans General Hospital, Taichung

University Hospitals Case Medical Center, Cleveland

Cleveland Clinic, Cleveland

University of Cincinnati Medical Center, Cincinnati

Barbara Ann Karmanos Cancer Institute, Detroit

Universitätsklinikum Köln, Cologne

Katholisches Klinikum Mainz, Sankt Hildegardis-Krankenhaus, Mainz

Ospedale Civile di Livorno, Livorno

Northwestern University, Chicago

University of Illinois Cancer Center, Chicago

Illinois Cancer Specialists, Niles

Oncology Hematology West PC, Omaha

Texas Oncology, P.A., Bedford

Houston Methodist Cancer Center, Houston

The University of Texas - MD Anderson Cancer Center, Houston

Texas Oncology-Beaumont, Beaumont

Texas Oncology, PA, Austin

University of Colorado Cancer Center, Aurora

Asklepios Fachkliniken München-Gauting, Gauting

Comprehensive Cancer Centers of Nevada, Henderson

University of Southern California, Norris Comprehensive Cancer Center, Los Angeles

UCLA Medical Center, Santa Monica

The Oncology Institute of Hope and Innovation, Whittier

City of Hope, Duarte

East Valley Hematology and Oncology Medical Group, Inc., Burbank

Compassionate Cancer Care Medical Group, Inc., Fountain Valley

Sansum Clinic, Santa Barbara

Central Coast Medical Oncology Corporation, Santa Maria

University of California San Francisco, San Francisco

Sutter Medical Group, Sacramento

Oregon Health and Science University, Portland

University of Washington, Seattle

Northwest Cancer Specialists, P.C., Vancouver

Yakima Valley Memorial Hospital, North Star Lodge, Yakima

St. Joseph Heritage Healthcare, Fullerton

UC San Diego Moores Cancer Center, La Jolla

Regional Cancer Care Associates, LLC, East Brunswick

Regional Cancer Care Associates, Morristown

USC/Norris Comprehensive Cancer Center, Nashville

University of Texas Southwestern Medical Center, Dallas

Texas Oncology-Plano East, Plano

Evangelische Lungenklinik Berlin, Berlin

Prince of Wales Hospital, Hong Kong

Queen Mary Hospital, Hong Kong

Dong-A University Hospital, Busan

Inha University Hospital, Incheon

Seoul National University Bundang Hospital, Seongnam-si

Severance Hospital, Yonsei University Health System, Seoul

Samsung Medical Center, Seoul

Asan Medical Center, Seoul

The Catholic University of Korea Saint Vincent's Hospital, Suwon

Hospital Universitario Vall d'Hebron, Barcelona